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ABSTRACT
Objectives
Childhood cancer poses a significant public health burden, both globally and in the
United States (US). The most common childhood cancers affect the brain and central
nervous system (CNS). Age-adjusted childhood brain tumor (CBT) incidence rates in
Kentucky are larger than in the rest of the US; these rates are also higher in Appalachian
Kentucky than in the rest of the state. This study determined if high-rate clusters of either
CNS tumor or retinoblastoma existed in Kentucky.
Methods
Data for this study were retrieved from the Kentucky Cancer Registry for the years 1995
through 2014. Cases were individuals between the ages of 0 and 19 years that were
diagnosed with either retinoblastoma (N=81) or a CNS tumor (N=1042). Population data
for demographic subgroups defined by binary combinations of age, sex, and race were
obtained from the CDC WONDER Bridged-Population database. Spatial scan statistics,
used to identify high-rate clusters of CBT, were implemented using SaTScan Version
9.4.4. Clusters were mapped using ArcGIS version 10.4.1.
Results
One significant high-rate cluster of CNS tumor cases was identified across the northern
part of Appalachian Kentucky and northern and central parts of Kentucky (p<0.0001), but
there were no significant high-rate clusters of retinoblastoma cases.
Conclusions
The significant cluster identified by the spatial scan statistic somewhat corresponds to
previous findings indicating a higher rate of these cancers in the Appalachian region, but
it was not confined to Appalachia. Future aims of this pilot study are to identify possible
risk factors that may be causing this increase.
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INTRODUCTION
Childhood cancer poses a significant global public health burden, with between
175,000 and 250,000 incident cases annually.1 While approximately 90% of childhood
cancer cases occur in developing countries, the American Cancer Society (ACS)
estimates that, in 2017, 10,270 incident cases of cancer will be diagnosed among
children, aged 14 years and under, in the United States (U.S.), where incidence rates for
childhood cancers have increased annually by 0.6% since 1975.1,2 Although mortality
rates have decreased from 6.5 to 2.0 (per 100,000 persons) between 1969 and 2014, it is
estimated that 1,190 deaths from childhood cancer will occur in 2017; the US relative
survival rate for all childhood cancers is 83%.2
The most common solid tumors that affect children occur in the brain and central
nervous system (CNS) (26% of all childhood cancers), with a five-year survival rate of
79%.2 The histological subtypes of childhood brain tumors (CBTs) include gliomas
(which arise from glial cells) and tumors of embryonic cells (which develop if these cells
are present in the CNS post-partum).3-5 The most common CBT in children, aged 14
years and under, is pilocytic astrocytoma, which comprises 17% of all CNS tumors in
children; incidence rates are between 0.74 to 0.9 (per 100,000 persons), with a 10-year
survival rate greater than 96%.3,6 Retinoblastoma comprises 2% of all cancers diagnosed
in children under age 5 years and has a five-year survival rate of 95%.7 Less common
forms of CBT include brain stem glioma, diffuse astrocytoma, high-grade astrocytoma,
primitive neuroectodermal tumor (PNET), medulloblastoma, and atypical
teratoid/rhabdoid tumor (ATRT).3,5
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There are currently few recognized risk factors for CBTs, including ionizing
radiation exposure and certain cancer syndromes, though there have been several studies
where researchers examined other potential risk factors3,8-30 These include advanced
parental age, parental exposures (i.e., maternal nutrition, cigarette smoking, proximity to
radiofrequency electromagnetic fields, paternal occupational exposure to radiation or
chemicals), high socioeconomic status, birth defects, markers of fetal growth, genotype
interactions, residential pesticide exposure, and certain infections.
Previously, researchers conducted a study comparing pediatric brain tumor
incidence in Appalachian versus non-Appalachian regions to determine if astrocytoma
risk among Appalachian children was greater than national rates. From the North
American Association of Central Cancer Registries (NAACR), for the years 2001
through 2011, Huang, et. al., identified CNS tumor cases, diagnosed in approximately
27,000 non-Appalachian and 2,200 Appalachian individuals between the ages of 0 and
19. Here, researchers determined that pediatric CNS tumor incidence rates (reported per
100,000 with 95% confidence intervals (CIs)) were greater among Appalachian (3.31,
3.17-3.45) cases than among non-Appalachian cases (3.06,3.02-3.09). Additionally, from
the years 2004 through 2011, researchers determined that World Health Organization
(WHO) grade I astrocytomas were greater in Appalachia (0.63, 0.56-0.70) than in nonAppalachia (0.44, 0.43-0.46).31
Presenters to the Interim Joint Committee on Health and Welfare (September 21,
2016) observed that age-adjusted childhood cancer incidence rates, from 1999 through
2013 (per 1,000,000), when compared to the entire state of Kentucky and to the U.S., are
larger in Appalachian Kentucky; that is, 184.0 compared to 176.0 and 174.0 in Kentucky
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and in the U.S.32 These differences were statistically significant (p<0.05) among males
(age-adjusted incidence of 202.0 per 1,000,000 compared to 188.0 for the entire state and
182.0 for the U.S.). Incidence rates for CNS cancers were also significantly higher when
comparing Appalachian Kentucky to the U.S. (approximately 40.0 per 1,000,000 versus
approximately 32.0 per 1,000,000).
Table 1.1 shows age-adjusted incidence rates (per 1,000,000) and 95% confidence
intervals (CIs) for pediatric CNS tumors and retinoblastoma for individuals between ages
0 and 19 years from 2010 through 2014.33,34 Rates are shown for Appalachian Kentucky,
the whole state of Kentucky, and the U.S.; these are considered significantly different
from each other since CIs do not overlap. During this time period, incidence rates of CNS
tumor were significantly greater in Appalachian Kentucky (45.7, 35.4-58.0) and the
whole state of Kentucky (40.5, 35.4-46.1) than in the U.S. (32.2, 31.6-32.7). The
incidence rate for retinoblastoma cases in Appalachian Kentucky during this period was
not stable from 2010 to 2014 because the case count was less than 15; this is marked in
the table with an asterisk. There were no statistically significant differences when
comparing incidence rates for retinoblastoma.
To investigate this phenomenon, the present study focused on identifying regions
of Kentucky where clusters of CBTs exist. CBTs of interest for this study include CNS
cancers defined by site groupings specified by the International Classification of
Childhood Cancer (ICCC). These site groupings are based on the International
Classification of Diseases for Oncology (ICD-O-3) and the World Health Organization
(WHO) Classification of Tumors of Haemotopoietic and Lymphoid Tissues (2008) (ICDO-3/WHO 2008); groupings are based on site and histology combinations. Cancer groups
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for this project include “III CNS and miscellaneous intracranial and intraspinal
neoplasms” and “V Retinoblastoma”.35 Throughout this paper, these defined cancer
groups will be referred to as CNS tumor and retinoblastoma.
The results of this study will be used to guide further research into this topic,
including later identifying possible risk factors that may be associated with increased risk
of either CNS tumor or retinoblastoma within significant clusters. After determining risk
factors within clusters, these results can be used to target interventions and reduce
pediatric CNS tumors and/or retinoblastoma in high-rate areas.
LITERATURE REVIEW
A literature review was completed using PubMed, an online database containing
peer-reviewed publications that pertain to life and biomedical sciences; this is maintained
by the United States National Library of Medicine at the National Institutes of Health.
The following keyword searches were performed to identify pertinent resources:
“childhood brain tumors”, “childhood astrocytoma risk”, and “childhood CNS tumors
risk”. Results were restricted to those publications that were published within the past 10
years and studied human subjects.
Prenatal Factors/Parental Exposures
Several researchers have assessed the relationship between CBTs and prenatal
risk factors, including environmental exposures among parents (i.e., maternal nutrition,
parental smoking, and parental environmental exposures).
These studies show that dietary factors and nutritional supplements may have a
protective effect against CBTs. In an international case-control study looking at cases
diagnosed between 1982 and 1992 Pogoda, et. al., revealed that maternal consumption of
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cruciferous vegetables and fresh fish significantly reduced the risk of anaplastic
astrocytoma and astroglial tumor.29 Milne, et. al. (2012), in an Australian case-control
study conducted between 2005 and 2011, showed that mothers who used folic acid
supplements prior to pregnancy had children with the lowest risk of CBT; risk was also
lower among children of mothers that used supplements during pregnancy.22 A different
study identified a possible negative association between pre-pregnancy folic acid
supplementation and CBT risk where a mother, father, or child has the MTRR 66GG
genotype; this genotype alone, however, does not significantly decrease the risk when it
is present in a child or father.30 Conversely, Mortensen, et. al., who conducted a
population-based cohort study in Norway reported that there was not an association
between maternal supplemental folic acid use and CBT tumor risk in their offspring.25
Published literature indicates that there are no significant associations between
CBT risk and parental smoking either during or prior to pregnancy. Huang, et. al.,
performed a meta-analysis and found that relative risks were not greater for children of
either mothers or fathers that smoked; results were consistent when assessing if risk
increased with dose of cigarette smoke.19 Milne, et. al. (2013), in an Australian
population-based case-control study reported similar results, with no significant ORs for
any parental smoking.23 Barrington-Trimis, et. al., in a case-control study examining
polymorphism genotypes using neonatal dried blood spots, found that high-risk genotype
EPHX1 H139R increased risk of CBT, with an additional dose-response pattern for
paternal smoking; these results, however, were not statistically significant.9
Multiple researchers have conducted case-control studies to assess other parental
exposures. Assessing maternal exposure to mobile phone base stations during pregnancy,
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Elliott, et. al., reported no significant associations to CBT risk.16 Keegan, et. al.,
considered paternal occupation and social class, as derived from fathers’ occupations at
the time of their child’s birth, and observed significantly increased CNS tumor risk for
children with fathers exposed to farm animals (OR=1.40, 95% CI 1.01-1.94) and to lead
(OR=1.18, 95% CI 1.01-1.39). Increased risk associated with exposure to farm animals
may be related to pesticide exposure, and the effect of lead was only significant after
adjusting for social class.21 In a study of parental occupational solvent exposure, Peters,
et. al., reported a significantly increased risk for children with fathers who were exposed
to aromatic solvents other than benzene (OR=1.76, 1.10-2.82).28
Perinatal Risk Factors
Several researchers have conducted studies to determine if associations exist
between the development of CBTs and several perinatal risk factors (i.e., fetal growth,
maternal/familial history, maternal infections, and birth defects).
High fetal growth is a term used to describe the development of infants who are
large for gestational age (LGA).14 An infant that is LGA has a birthweight that is greater
than the 90th percentile for their gestational age. LGA can occur for multiple reasons,
including genetic factors, a mother gaining excessive weight during pregnancy, and
maternal diabetes. Many of the problems associated with LGA children include increased
incidence of birth defects, low blood sugar (LBS or hypoglycemia) after delivery, and
respiratory distress.36
Multiple researchers have recognized that there is an association between high
fetal growth and an increased risk for CBTs.10,14,27 O’Neill, et. al., in a population-based
case-control with study data from the U.S. and the United Kingdom (U.K.), observed
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high birth weight was associated with an increased risk of CNS tumors in both datasets,
reported as odds ratios (ORs) with 95% CIs (U.S. OR=1.10, 1.06-1.13; U.K. OR=1.07,
1.04-1.10).27 Crump, et. al., in a Swedish cohort study that followed subjects born
between 1973 and 2008, observed that subjects with high fetal growth had significantly
increased risk, independent of gestational age; results here suggest that growth factor
pathways may be important to the etiology of certain brain tumors.14 Bhatti, et. al., in a
Washington state case-control study testing for circulating vitamin D3 levels from
neonatal blood spots in birth records, observed that children with higher birth weights had
greater vitamin D3 levels in their blood and were at greater risk of developing CBT; ORs,
presented with 95% CIs, comparing higher to lower birth weight children in quartiles of
vitamin D3 levels (2nd=1.7, 1.0-3.3; 3rd=2.4, 1.2-4.8; 4th=2.6; 1.2-5.6).10 Since vitamin D3
concentrations are affected by insulin-like growth factor 1 (IGF-1), this may be a growth
factor pathway influencing the results of the above Swedish study.10 Milne, et. al. (2008),
who conducted a Western Australian population-based cohort study using intra-uterine
growth measures rather than birth weight, however, observed that there was little
evidence that fetal growth was associated with CNS tumor development.24
Researchers have also examined the relationship between maternal and familial
history.11,14 Cantwell, et. al., in a Northern Ireland population-based cohort study that
following persons born between 1971 and 1986, found that the risk of CBT was
significantly greater among children born into larger families or to mothers with an
obstetric history of miscarriage, reported with a 95% CI (OR=1.68, 1.16-2.42).11 In the
previously mentioned Swedish study, Milne, et. al., (2008), observed that risk of CBT
was greatest among those with a first degree history of brain tumor and those born to
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mothers with high educational achievement.14 This may relate to the findings of a
California study that reported risk of glioma increased with maternal age over 35 years
(OR=1.87, 1.00-3.52).26 In a U.S. population-based case-control study of data pooled
from five states, Carozza, et. al., reported a similar association, recognizing that ORs for
astrocytoma were reduced by 30 to 40% for lower parental education levels.12 Johnson,
et. al., in a similar multi-state study, observed a significant increase in childhood CNS
tumors, with positive linear trends per five-year maternal age increase (OR=1.07, 1.031.10).20
Related studies have been conducted to assess the relationship between maternal
infections, childhood birth defects, and CBT risk in California. In a case-control study of
children under age 16 years diagnosed with CNS tumors between 1988 and 2008,
Oksuzyan, et. al., found that mothers with genital herpes or blood/immune disorders
during pregnancy had children with significantly greater risk of CNS tumors
(respectively, 2.74, 1.16-6.51; and 2.28, 1.08-4.83). Researchers also observed a
protective effect for mothers with non-sexually transmitted infections (STIs) during
pregnancy (0.28, 0.09-0.85).26 Fisher, et. al., in a population-based cohort study of
children born between 1988 and 2004, recognized that childhood cancer risk is greater in
children with chromosomal birth defects, reported as hazard ratio (HR) with a 95% CI
(HR=12.44, 10.10-15.32); risk was also greater with non-chromosomal birth defects,
especially for brain and other solid tumors (1.58, 1.33-1.87).17
Childhood Exposures
Fewer researchers have assessed the role of childhood exposures. Dobbins, et. al.,
in a case-control study considering the influence of genotype on asthma and glioma risk
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found that the single nucleotide polymorphism (SNP) region rs7216389 tags the 3’
flanking region of ORMDL3 at 17q21; this is significantly associated with both asthmas
and increased risk of glioma, reported as OR with 95% CI (1.10, 1.01-1.19).15 In a multinational case-control study that assessed social contacts and CNS tumor risk Andersen,
et. al., found that children with at least four sick days per month in their first six years of
life had a significantly increased risk of glioma, reported with 95% CI (OR=2.93, 1.575.50).8 These results make sense in the context of increased CBT risk observed by
Cantwell, et. al., in children born into families with at least three other children.11
Summary
The current literature provides evidence that several risk factors may be
associated with an increased risk for CBT, including parental occupational exposure to
animals, lead, and some aromatic solvents; higher circulating vitamin D3 levels in
neonates; high birth weight; being born into a larger family; being born to a mother with
a history of miscarriage; maternal age; maternal genital herpes; maternal blood/immune
disorders during pregnancy; being born with birth defects; having a genotype that
predisposes one to asthma; and frequent infections in the first six years of life. Evidence,
however, is most robust for the following risk factors: non-chromosomal birth defects,
paternal exposure to non-benzene aromatic solvents, high fetal growth that may be
related to circulating vitamin D3 levels, and maternal age over 35 years.
METHODS
Study Design and Data
This cross-sectional study was approved by the institutional review board of the
University of Kentucky on March 28, 2017. The Kentucky Cancer Registry (KCR)
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supplied data on CBT cases diagnosed from January 1, 1995 through December 31, 2014.
The KCR is Kentucky’s mandatory population-based central cancer registry and is part of
the Markey Cancer Control Program’s integrated cancer control effort; the KCR has
collected uniform data for all cancer cases among Kentucky residents since 1995.37 Data
for this study were obtained from the KCR for all cases of retinoblastoma and CNS
tumors in Kentucky for individuals aged 0 to 19 years from 1995 to 2014. The
retinoblastoma dataset included tumors identified for three histological subtypes; the
CNS tumor dataset included tumors for 56 histological subtypes.
Spatial scan statistics were used to identify high-rate clusters of CBT incidence in
Kentucky from 1995 to 2014. This technique was chosen because brain cancer is a rare
event, and county-level incidence rates are thus highly unstable. Spatial scan statistics,
unlike other common local cluster analysis options (e.g., local Moran’s I and Getis-Ord
Gi*), enable a Poisson-based analysis based on case and population counts. Spatial scan
statistics were implemented using SaTScan version 9.4.4.
SaTScan is a free software that analyzes spatial, temporal, and space-time data
using scan statistics. It was developed by Martin Kulldorff in association with
Information Management Services Incorporated, with financial support from multiple
divisions within the National Cancer Institute (NCI), the Alfred P. Sloan Foundation, the
Centers for Disease Control and Prevention (CDC), the National Institute of Child Health
and Development, and the National Institute of General Medical Sciences.38
Several researchers have used spatial scan statistics to identify high-rate brain
cancer clusters.39-41 Kulldorff, et. al., utilized spatial scan statistics to determine if rates of
brain cancer were not greater than expected in the Los Alamos neighborhood of New
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Mexico.39 Smith, et. al., used spatial scan statistics, in addition to other methods, to
determine if there were geographical clusters of childhood astrocytoma cases in
Sweden.40 Fang, et. al., used spatial scan statistics to investigate descriptive statistics that
indicated geographical differences of brain cancer mortality in the U.S.41
In a spatial scan statistic, circular or elliptical scan windows of varying sizes, are
centered on the centroids of every region, and are generated across the study area to
identify groups of contiguous regions that have significantly higher (or lower) rates of
disease than expected. These scan windows represent potential clusters, and sizes vary
continuously until the maximum population at risk is in the window. Windows in which
disease rates are greater (or less) than regions outside of the scan window are identified
as clusters. Space-time scan statistics are calculated using cylindrical scan windows, the
heights of which correspond to time periods for potential clusters. A Monte Carlo
simulation is used to determine p-values for scan statistics, comparing the calculated test
statistic to statistics that were generated under the null hypothesis that disease clusters did
not exist.38 Within clusters, p-values indicate the probability that disease rates are higher
(or lower) than rates in the rest of the study area.
Since a discrete Poisson distribution was used to model the probability of highrate clusters, we obtained population data from the CDC WONDER database BridgedRace Resident Population Estimates United States, State and County for the years 19902015. CDC WONDER data, rather than KCR data, was used for the population
denominator because population counts within specific demographic categories were
necessary to conduct adjusted analysis. Although KCR data uses Census data to provide
population estimates, these estimates are aggregated and are not provided by age, race, or
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sex. The CDC WONDER data, which comprise population estimates for each county in
Kentucky, were downloaded on April 17, 2017.42 We used the SaTScan software, along
with the population data and the case data, to calculate outcome rates within each county
and for each group defined by potential confounders (i.e., age, race, and sex).
For the years 1990 through 2009, inter-censal estimates of the July 1 resident
population were used; starting in 2010, July 1 post-censal estimates were used. Intercensal estimates are determined by taking into account two completed censuses and
adjusting post-censal series of estimates for differences between census population counts
and previously-calculated estimates; post-censal estimates are determined using measures
of population change. For the years where inter-censal estimates were used, county-level
data differs from state- and national-level data because rounding created some negative
population counts that were changed to a value of zero.
Variable Selection
We stratified the data by type of cancer. Thus, one case dataset included
retinoblastoma cases (N=81) only, and another dataset included all other CNS tumor
cases (N=1042). Variables available for analysis included year of diagnosis, county of
residence at time of diagnosis, age at diagnosis, sex, and race (white or non-white). The
geographical unit of analysis for this study was county of residence at time of diagnosis.
A new age variable was created by categorizing age at diagnosis as either 0 to 4 years of
5 to 19 years; these categories were chosen to maintain consistency with data previously
presented at the Interim Joint Committee on Health Welfare.32 Among the cases of
retinoblastoma, one individual’s race was “unknown”; there were 14 cases for whom race
was “unknown” in the CNS tumor dataset. Rather than excluding these cases, “unknown”
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race was changed to “white”, since the great majority of Kentucky’s population is white.
According to the 2010 US Census, 81% of Kentucky’s population ages 0 to 19 years is
“white”; this demographic was estimated as 79% in 2015.43
Analysis was adjusted for age, sex, and race to adjust for population differences
across regions of Kentucky. Population data, gathered for the years 1995 through 2014,
therefore, were stratified by age (using the age categories described above), sex, and race.
This created eight new demographic sub-groups, including white males aged 0 to 4 years,
white males aged 5 to 19 years, white females aged 0 to 4 years, white females aged 5 to
19 years, non-white males aged 0 to 4 years, non-white males aged 5 to 19 years, nonwhite females aged 0 to 4 years, and non-white females aged 5 to 19 years. This data was
collected for each county for each year during this time period.
Statistical Analysis
The number of cases in each county is Poisson distributed because the dataset
provides case count information, and CBT diagnoses occur independently. Therefore, the
discrete Poisson model was used for SaTScan analysis. Under this model, it is expected
that the number of diagnoses in each county is proportional to its population size. Since
we adjusted for demographic variables, an expected number of cases was calculated
(using SaTScan) for each of the eight demographic subgroups– combination of binary
age, race, and sex categories – across the study period. The purpose of adjusted analysis
was to account for effects of these covariates on retinoblastoma or CNS tumor incidence.
As previously mentioned, population differences exist across the regions of Kentucky,
and such factors may be related to development of CBT.
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A preliminary and purely spatial analysis – using a circular scan window with a
maximum 50% of the population at risk – was conducted first. Spatio-temporal analyses using circular scan windows with maximums of 50% and 25% of the population at risk –
were then conducted. After conducting these preliminary analyses, a second spatiotemporal analysis was conducted – using an elliptical scan window with a maximum of
25% of the population at risk – to characterize more specific temporal and spatial
patterns. For the spatio-temporal analyses, time was aggregated to year of diagnosis. A
significance level of 0.05 was used to determine if clusters had statistically significant
higher rates of either retinoblastoma or CNS tumor compared to the rest of Kentucky.
This analysis was conducted twice, once for retinoblastoma and once for CNS tumors.
Additionally, an analysis was conducted combining the retinoblastoma and CNS tumor
data to compare to results from the stratified analysis.
RESULTS
Table 2.1 and 2.2 provide a summary of demographics for cases of retinoblastoma
and CNS tumors, as well as the total populations within each demographic category in
Kentucky from 1995 through 2014.42 Total population information is provided for
comparison because case data was aggregated over this time period. Retinoblastoma
disproportionately affects males (60.5% of cases compared to 51.3% males aged 0 to 19
years in KY) and children aged 0 to 4 years (98.8% of cases compared to 24.3% of the 0to-4 year old population during this period). The majority of retinoblastoma cases
diagnosed between the ages of zero and four years is consistent with an average age of
three years reported in the literature.44 Additionally, the majority of retinoblastoma cases
(90.1%) were white. Among cases of CNS tumor, 48.7% were male and 51.3% were
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female. The majority of cases (73.6%) were between the ages of 5 and 19 years, and
91.2% of cases were white.
Tables 3.1 and 3.2 provide a summary of the elliptical scan statistics that were
calculated for cases of retinoblastoma and CNS tumors. None of the clusters identified in
the retinoblastoma dataset were significant. One statistically significant cluster was
identified in the CNS tumor dataset. The time frame for this cluster was January 1, 2007
to December 31, 2014. The relative risk within the cluster was 1.87, with a p-value of less
than 0.0001. This indicates that risk of developing a CNS tumor within these counties
during this period was approximately 87% greater than in the rest of the state.
Figures 1.1 and 1.2 show the clusters identified using elliptical scan windows and
setting the maximum population at risk to 25%. In these figures, the counties of
Appalachia are shown in grey. Figure 1.1 shows four high-rate clusters of retinoblastoma,
two of which lie in Appalachia; none of these clusters were statistically significant.
Figure 1.2 shows three high-rate clusters of CNS tumors, two of which are statistically
nonsignificant (indicated by black outlines). The statistically significant cluster has red
outlines and encompasses 40 counties. Approximately half of this cluster lies across part
of Appalachian Kentucky.45
Table 3.3 provides a summary of the analysis conducted for retinoblastoma and
CNS tumor cases combined. Similar to CNS tumor cases, one large significant cluster
(p=0.0004) was identified across the northern part of Appalachian Kentucky and the
northern central part of Kentucky; the time frame for this cluster was also January 1,
2007 through December 31, 2014 and included only four additional cases. Four other
clusters were identified, all of which were non-significant. Clusters 2 and 3 were similar
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in location to the non-significant clusters identified for CNS tumor, but had different time
frames than clusters identified for either retinoblastoma or CNS tumor. Additional nonsignificant clusters were identified in the north western part of Kentucky. The locations
of these clusters are shown in Figure 1.3.
DISCUSSION
The purpose of this study was to identify high-rate clusters of retinoblastomas or
other CNS tumors in Kentucky between the years 1995 and 2014 for individuals aged 0
to 19 years, after adjusting for basic demographic factors. No significant high-rate
clusters of retinoblastoma were observed. One significant high-rate cluster was observed
among those diagnosed with a CNS tumor, even after adjustment for race, sex, and age.
This finding was somewhat consistent with preliminary analysis suggesting that ageadjusted childhood cancer incidence rates in Appalachian Kentucky are higher than in the
rest of the state.32 This cluster of high rates, however, extended into portions of Central
and Northern Kentucky that are not generally considered Appalachia.
Comparison with Other Studies
Previous studies have indicated the utility of using spatial scan statistics to
identify high-rate clusters of brain cancer incidence.39-41 Kulldorff, et. al., used the spatial
scan statistic to confirm the findings of a public health review in New Mexico that excess
brain cancer mortality was not significantly higher in the region surrounding a nuclear
research facility in Los Alamos.39 Similarly, in this study we investigated findings from a
previous study that claimed higher CBT incidence in one region of Kentucky. As this is a
pilot study, however, additional studies will need to be conducted to investigate what

University of Kentucky

Khoury | 18

factors may be associated with increased diagnoses of CNS tumors in the cluster that was
identified.
Smith, et. al., conducted a population-based study of pediatric brain tumors in
Sweden, and found that there were no statistically significant clusters (either spatial or
temporal) found for cases of either astrocytoma or all cases of CNS tumor.40 Similarly,
we found a significant spatio-temporal cluster for cases of CNS tumor. This study,
however, included a broader age range (0 to 19 years versus 0 to 15 years) and had
defined geographic boundaries throughout the entire study period (Sweden’s parishes
have experienced minor geographic boundaries changes, so a geographically constant
standard had to be used). The risk factors of these populations are likely also different,
highlighting the need for geographical analyses of CBT incidence in different regions.
Investigating previously published descriptive statistics on brain cancer mortality
in the United States, Fang, et. al., used the spatial scan statistic to determine if high-rate
geographical clusters existed in certain regions. In that study, significantly higher
mortality was found among all adults in Southern west Kentucky and among men in of
Western Kentucky and Tennessee, in addition to higher rates in other parts of the U.S.41
Although this study used a similar methodology, it focused on the United States as a
whole rather than Kentucky. Additionally, a cluster of individuals under age 20 years in
Western Kentucky and Tennessee were non-significant.41 This may be due to less
mortality among children compared to adults, but also to smaller case counts. The only
cluster we identified in this region of Kentucky was for retinoblastoma – which has a
five-year survival rate of 95% – and was also non-significant.7
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Possible Risk Factors for CNS Tumor
The present study identified a region of Kentucky with greater than expected
diagnoses of CNS tumors in children; currently, evidence is inconsistent about risk
factors. The Kentucky Birth Surveillance Registry (KBSR), which provides birth
statistics for Kentucky from 2005 through 2014, produced a map (Figure 2.1) displaying
rates of major non-chromosomal birth defects (including neural tube defects) by region.46
The statistically significant cluster shown in Figure 2.2 encompasses two of the regions
with the highest rates of birth defects, but also includes regions with lower rates. It is not
possible, however, to conclude there is an association between birth defects and the
identified cluster because it is not possible to compare rates at different scales. There is
limited data available for infant birth weight and maternal age by either county or region
in Kentucky, and recent requests for data from the Kentucky Cabinet for Health and
Family Services have not been successful. In future analysis, it would be beneficial to
link vital statistics records to cases in the KCR dataset, to determine if rates of CNS
tumor are greater in regions with LGA infants and/or mothers age 35 years and older.
Data is not available regarding paternal occupational exposures to non-benzene aromatic
solvents.
Strengths and Limitations
The main strength of this study was the completeness of the datasets from the
KCR and the CDC WONDER database. KCR data has been uniformly collected since the
registry was mandated in 1995, providing twenty years of information on case
demographics and county of residence. Therefore, it was possible to compare data over
the study period to identify where clusters existed within the study. This is also beneficial
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for determining possible causes of increased CBT rates within clusters. The CDC
WONDER database uses census information to estimate population counts, and has a
defined method for calculating population in non-census years. Therefore, it was possible
to create defined demographic subgroups to conduct adjusted analysis.
This study had multiple limitations. Kentucky consists of 120 counties, some
having considerably smaller populations than others and would have expected rates of
retinoblastoma or CNS tumor close to zero. Compared to counties with larger
populations, this could increase the rate of diagnosis in a county or region in some years
and increase the spatial scan statistic within a cluster, influencing where high-rate clusters
were identified. Adjusting for age, race, and sex, however, reduced these effects. Small
populations also influence the maximum population at risk, as more counties would have
to be included in a cluster to meet the pre-determined window size. To minimize the
radius of scan windows and ensure that only counties with truly higher rates of diagnoses
were included in clusters, the maximum population at risk was defined as 25% rather
than 50%.
Small case counts exist because cancer, especially retinoblastoma, is a rare event.
Regions in which retinoblastoma cases were diagnosed, therefore, sometimes appear to
have high incidence rates when any diagnoses were made. Analyzing data over a long
time period increases case counts, and may lead to the identification of significant
clusters. The earlier presentation to the Interim Joint Committee on Health and Welfare –
that indicated high incidence rates of CNS tumors (significant) and retinoblastoma (nonsignificant) – analyzed data from diagnoses made between 1999 and 2013. Therefore, we
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looked at cases from 1995 through 2014. No significant clusters of retinoblastoma were
identified however, so future analysis would benefit from additional years of data.
Race was “unknown” and changed to “white” for fifteen cases. This may have
influenced analysis because of the small case counts in each year of the study period.
Although race was adjusted for in analysis, changing race in the dataset could lead to an
underestimation of retinoblastoma or CNS tumor incidence among those who are nonwhite.
Future Directions
In the present study, it was not possible to assess the relationship between
possible risk factors and the high-risk CNS tumor cluster that was identified because
necessary data was not available. Following this exploratory analysis, future plans are to
explore what factors are contributing to increased rates of CNS tumor in the cluster
detected by the spatial scan statistic. Since it is not possible, with data from the KBSR, to
conclude that birth defects are greater in the cluster region than in the rest of the state, it
would be worthwhile to obtain birth defect data to conduct further analysis. Additionally,
data for birth weight and maternal age need to be examined to compare CNS tumor rates
in this region to the rest of the state after adjusting for those factors. This could be done
by linking birth records to cases in the KCR dataset. To further investigate the impact of
paternal occupational exposure to solvents, a case-control study could be conducted
within the region of the statistically significant cluster.
CONCLUSIONS
This preliminary study identified one statistically significant high-rate cluster for
cases of CNS tumor for individuals aged 0 to 19 years in Kentucky between 1995 and
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2014, but did not identify significant high-rate clusters of retinoblastoma. This cluster
was across the northern part of Appalachian Kentucky and northern and central parts of
the state. While this somewhat corresponds to previous findings, it is important to note
that this cluster was not confined to Appalachia. Because there are currently not data
available to investigate why this cluster exists, future aims as a result of findings from
this pilot study are to identify possible risk factors that may be causing this increase.

University of Kentucky

Khoury | 23

REFERENCES
1.
2.
3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

2017; http://www.childhoodcancerinternational.org/. Accessed February 5, 2017.
Cancer Facts & Figures 2017. Atlanta, GA 2017.
Johnson KJ, Cullen J, Barnholtz-Sloan JS, et al. Childhood brain tumor
epidemiology: a brain tumor epidemiology consortium review. Cancer
epidemiology, biomarkers & prevention : a publication of the American
Association for Cancer Research, cosponsored by the American Society of
Preventive Oncology. 2014;23(12):2716-2736.
Bauchet L, Rigau V, Mathieu-Daude H, et al. Clinical epidemiology for
childhood primary central nervous system tumors. Journal of neuro-oncology.
2009;92(1):87-98.
Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization
Classification of Tumors of the Central Nervous System: a summary. Acta
neuropathologica. 2016;131(6):803-820.
Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: Primary brain
and central nervous system tumors diagnosed in the United States in 2006-2010.
Neuro-oncology. 2013;15 Suppl 2:ii1-56.
Retinoblastoma - Childhood: Statistics. [Web]. 2005-2017;
http://www.cancer.net/cancer-types/retinoblastoma-childhood/statistics. Accessed
June 30, 2017.
Andersen TV, Schmidt LS, Poulsen AH, et al. Patterns of exposure to infectious
diseases and social contacts in early life and risk of brain tumours in children and
adolescents: an International Case-Control Study (CEFALO). British journal of
cancer. 2013;108(11):2346-2353.
Barrington-Trimis JL, Searles Nielsen S, Preston-Martin S, et al. Parental
smoking and risk of childhood brain tumors by functional polymorphisms in
polycyclic aromatic hydrocarbon metabolism genes. PloS one.
2013;8(11):e79110.
Bhatti P, Doody DR, McKean-Cowdin R, Mueller BA. Neonatal vitamin D and
childhood brain tumor risk. International journal of cancer. 2015;136(10):24812485.
Cantwell MM, Forman MR, Middleton RJ, Murray LJ. Association of early life
factors and brain tumour risk in a cohort study. British journal of cancer.
2008;99(5):796-799.
Carozza SE, Puumala SE, Chow EJ, et al. Parental educational attainment as an
indicator of socioeconomic status and risk of childhood cancers. British journal of
cancer. 2010;103(1):136-142.
Chen M, Chang CH, Tao L, Lu C. Residential Exposure to Pesticide During
Childhood and Childhood Cancers: A Meta-Analysis. Pediatrics.
2015;136(4):719-729.
Crump C, Sundquist J, Sieh W, Winkleby MA, Sundquist K. Perinatal and
familial risk factors for brain tumors in childhood through young adulthood.
Cancer research. 2015;75(3):576-583.
Dobbins SE, Hosking FJ, Shete S, et al. Allergy and glioma risk: test of
association by genotype. International journal of cancer. 2011;128(7):1736-1740.

University of Kentucky
16.

17.

18.

19.
20.
21.

22.

23.
24.

25.
26.

27.

28.

29.

30.

Khoury | 24

Elliott P, Toledano MB, Bennett J, et al. Mobile phone base stations and early
childhood cancers: case-control study. BMJ (Clinical research ed).
2010;340:c3077.
Fisher PG, Reynolds P, Von Behren J, Carmichael SL, Rasmussen SA, Shaw GM.
Cancer in children with nonchromosomal birth defects. The Journal of pediatrics.
2012;160(6):978-983.
Greenop KR, Blair EM, Bower C, Armstrong BK, Milne E. Factors relating to
pregnancy and birth and the risk of childhood brain tumors: results from an
Australian case-control study. Pediatric blood & cancer. 2014;61(3):493-498.
Huang Y, Huang J, Lan H, Zhao G, Huang C. A meta-analysis of parental
smoking and the risk of childhood brain tumors. PloS one. 2014;9(7):e102910.
Johnson KJ, Carozza SE, Chow EJ, et al. Parental age and risk of childhood
cancer: a pooled analysis. Epidemiology (Cambridge, Mass). 2009;20(4):475-483.
Keegan TJ, Bunch KJ, Vincent TJ, et al. Case-control study of paternal
occupation and social class with risk of childhood central nervous system tumours
in Great Britain, 1962-2006. British journal of cancer. 2013;108(9):1907-1914.
Milne E, Greenop KR, Bower C, et al. Maternal use of folic acid and other
supplements and risk of childhood brain tumors. Cancer epidemiology,
biomarkers & prevention : a publication of the American Association for Cancer
Research, cosponsored by the American Society of Preventive Oncology.
2012;21(11):1933-1941.
Milne E, Greenop KR, Scott RJ, et al. Parental smoking and risk of childhood
brain tumors. International journal of cancer. 2013;133(1):253-259.
Milne E, Laurvick CL, Blair E, de Klerk N, Charles AK, Bower C. Fetal growth
and the risk of childhood CNS tumors and lymphomas in Western Australia.
International journal of cancer. 2008;123(2):436-443.
Mortensen JH, Oyen N, Fomina T, et al. Supplemental folic acid in pregnancy
and childhood cancer risk. British journal of cancer. 2016;114(1):71-75.
Oksuzyan S, Crespi CM, Cockburn M, Mezei G, Kheifets L. Birth weight and
other perinatal factors and childhood CNS tumors: a case-control study in
California. Cancer epidemiology. 2013;37(4):402-409.
O'Neill KA, Murphy MF, Bunch KJ, et al. Infant birthweight and risk of
childhood cancer: international population-based case control studies of 40 000
cases. International journal of epidemiology. 2015;44(1):153-168.
Peters S, Glass DC, Greenop KR, et al. Childhood brain tumours: associations
with parental occupational exposure to solvents. British journal of cancer.
2014;111(5):998-1003.
Pogoda JM, Preston-Martin S, Howe G, et al. An international case-control study
of maternal diet during pregnancy and childhood brain tumor risk: a histologyspecific analysis by food group. Annals of epidemiology. 2009;19(3):148-160.
Greenop KR, Scott RJ, Attia J, et al. Folate pathway gene polymorphisms and risk
of childhood brain tumors: results from an Australian case-control study. Cancer
epidemiology, biomarkers & prevention : a publication of the American
Association for Cancer Research, cosponsored by the American Society of
Preventive Oncology. 2015;24(6):931-937.

University of Kentucky
31.
32.
33.

34.

35.
36.

37.
38.
39.

40.

41.
42.
43.
44.
45.
46.

Khoury | 25

Huang B, Luo A, Durbin EB, et al. Incidence of CNS tumors in Appalachian
children. Journal of neuro-oncology. 2017;132(3):507-512.
Durbin EB, Wagner, L., Bathje, K. Childhood Cancer in Kentucky. September 21
2016.
2014 Childhood Cancer (detailed by ICCC group). United States Cancer Statistics
(USCS): 1999-2014 Incidence and Mortality Web-based Report [Web]. 2017;
www.cdc.gov/uscs. Accessed July 2017.
Age-Adjusted Invasive Cancer Incidence Rates by County in Kentucky, 20102014. Kentucky Cancer Registry; 2017. http://www.cancer-rates.info/ky/.
Accessed Jun 30, 2017.
International Classification of Childhood Cancer (ICCC).
https://seer.cancer.gov/iccc/. Accessed July 10, 2017.
Large for Gestational Age (LGA).
http://www.stanfordchildrens.org/en/topic/default?id=large-for-gestational-agelga-90-P02383. Accessed June 8, 2017.
History of Cancer Reporting in Kentucky. Accessed May 18, 2017.
Kulldorff M. SaTScan User Guide. for version 9.42015:6-9.
Kulldorff M, Athas WF, Feurer EJ, Miller BA, Key CR. Evaluating cluster
alarms: a space-time scan statistic and brain cancer in Los Alamos, New Mexico.
American journal of public health. 1998;88(9):1377-1380.
Smith MA, Freidlin B, Ries LA, Simon R. Increased incidence rates but no spacetime clustering of childhood astrocytoma in Sweden, 1973-1992: a populationbased study of pediatric brain tumors. Cancer. 2000;88(6):1492-1493.
Fang Z, Kulldorff M, Gregorio DI. Brain cancer mortality in the United States,
1986 to 1995: a geographic analysis. Neuro-oncology. 2004;6(3):179-187.
Bridged-Race Resident Population Estimates United States, State and County for
the years 1990-2015. Accessed May 18, 2017.
Annual County Resident Population Estimates by Age, Sex, Race, and Hispanic
Origin: April 1, 2010 to July 1, 2015. In: Population Division USCB, ed2016.
What is retinoblastoma? https://www.stjude.org/disease/retinoblastoma.html.
Accessed June 8, 2017.
Counties in Appalachia. https://www.arc.gov/counties. Accessed June 8, 2017.
Ferrell E CM, Kitchens B, Robl J, Shepherd RA, White CG. Ten Years of
Prevention: The Kentucky Birth Surveillance Registry 2005-2014. Kentucky
Department for Public Health; August 2016.

University of Kentucky

Khoury | 26
Appendix

Table 1.1: Age-adjusted incidence rates of Pediatric CNS tumor and retinoblastoma
cases per 1,000,000, Ages 0 to 19 Years, 2010 through 2014
Appalachian KY State of Kentucky

United States

CNS tumors

45.7 (35.4-58.0)

40.5 (35.4-46.1)

32.2 (31.6-32.7)

Retinoblastoma

6.8 (3.3-12.5)*

4.0 (2.5-6.0)

3.3 (3.1-3.4)

Table 1.1 displays age-adjusted incidence rates per 1,000,000 of CNS tumor and
retinoblastoma from 2010 through 2014, for individuals aged 0 to 19 years.33,34 Shown in
parentheses are 95% confidence intervals. Rates are significantly different when
confidence intervals do not overlap. An asterisk (*) indicates that rates are unstable do to
case counts under 15.
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Table 2.1: Retinoblastoma Case Demographics, Kentucky, 1995 through 2014

Race
White
Non-White
Sex
Male
Female
Age
0-4 Years
5-19 Years

Retinoblastoma
Cases (N=81)
n (%)

Kentucky
(N=22,459,624)
n (%)

73 (90.1%)
8 (9.9%)

19,818,448 (88.2%)
2,641,176 (11.8%)

49 (60.5%)
32 (39.5%)

11,525,495 (51.3%)
10,934,129 (48.7%)

80 (98.8%)
1 (1.2%)

5,447,740 (24.3%)
17,011,884 (75.7%)

Table 2.1 displays the demographics of retinoblastoma cases, in addition to demographics
for all individuals aged 0 to 19 years in Kentucky from 1995 through 2014.
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Table 2.2: CNS Tumor Case Demographics, Kentucky, 1995 through 2014

Race
White
Non-White
Sex
Male
Female
Age
0-4 Years
5-19 Years

CNS tumor
(N=1042)
n (%)

Kentucky
(N=22,459,624)
n (%)

950 (91.2%)
92 (8.8%)

19,818,448 (88.2%)
2,641,176 (11.8%)

507 (48.7%)
535 (51.3%)

11,525,495 (51.3%)
10,934,129 (48.7%)

275 (26.4%)
767 (73.6%)

5,447,740 (24.3%)
17,011,884 (75.7%)

Table 2.2 displays the demographics of CNS tumor cases, in addition to demographics
for all individuals aged 0 to 19 years in Kentucky from 1995 through 2014.
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Table 3.1: Retinoblastoma Spatial Scan Statistic Summary Using Elliptical Scan
Window with 25% Maximum Population at Risk, Kentucky, 1995 through 2014
Time
Number Expected Observed/ Relative
Test
pFrame
of Cases
Cases
Expected
Risk
Statistic value
Cluster 1/1/2010 to
8
0.92
8.68
9.52
9.93
0.171
1
12/31/2011
Cluster 1/1/1999 to
2
0.028
71.59
73.38
6.59
0.928
2
12/31/2000
Cluster 1/1/2013 to
4
0.24
16.54
17.35
6.54
0.935
3
12/31/2013
Cluster 1/1/2009 to
2
0.039
50.71
51.97
5.80
0.983
4
12/31/2009
Table 3.1 displays summary values from calculating spatial scan statistics for the
retinoblastoma dataset. There were no statistically significant high-rate clusters in this
dataset.
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Table 3.2: CNS Tumor Spatial Scan Statistic Summary Using Elliptical Scan
Window with 25% Maximum Population at Risk, Kentucky, 1995 through 2014
Number Expected Observed/ Relative
Test
Time Frame
p-value
of Cases
Cases
Expected
Risk
Statistic
Cluster 1/1/2007 to
179
104.04
1.72
1.87
20.19
>0.0001
1
12/31/2014
Cluster 1/1/2009 to
6
0.56
10.68
10.73
8.78
0.551
2
12/31/2009
Cluster 1/1/2004 to
64
34.86
1.84
1.89
7.58
0.878
3
12/31/2013
Table 3.2 displays summary values from calculating spatial scan statistics for the CNS
tumor dataset. There was one statistically significant high-rate cluster (Cluster 1) in this
dataset.
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Table 3.3: Retinoblastoma and CNS Tumor Combined Analysis Spatial Scan
Statistic Summary Using Elliptical Scan Window with 25% Maximum Population
at Risk, Kentucky, 1995 through 2014
Time Frame
Cluster
1
Cluster
2
Cluster
3
Cluster
4
Cluster
5

1/1/2007 to
12/31/2014
1/1/2005 to
12/31/2014
1/1/2006 to
12/31/2013
1/1/2009 to
12/31/2010
1/1/2004 to
12/31/2013

Number
of Cases
183

Expected
Cases
110.60

Observed/
Expected
1.65

Relative
Risk
1.78

Test
Statistic
17.93

p-value

30

11.05

2.71

2.76

9.67

0.353

153

107.36

1.43

1.49

7.16

0.939

10

2.64

3.79

3.81

5.98

0.999

26

11.97

2.17

2.20

5.87

0.999

0.0004

Table 3.3 displays summary values from calculating spatial scan statistics for the
Retinoblastoma and CNS tumor datasets. There was one statistically significant high-rate
cluster (Cluster 1) in this dataset.
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Figure 1.1: High-Rate Clusters of Retinoblastoma Identified by Spatial Scan
Statistics

This map displays the four high-rate clusters of retinoblastoma diagnoses identified by
spatial scan statistics, none of which are statistically significant.
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Figure 1.2: High-Rate Clusters of CNS Tumor Identified by Spatial Scan Statistics

Figure 1.2 displays the three high-rate clusters of CNS tumor diagnoses identified by
spatial scan statistics, only one of which is statistically significant (outlined in red, with
counties labeled).
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Figure 1.2: High-Rate Clusters of Retinoblastoma and CNS Tumor Identified by
Spatial Scan Statistics

Figure 1.3 displays the five high-rate clusters of Retinoblastoma and CNS tumor
diagnoses identified by spatial scan statistics, only one of which is statistically significant
(outlined in red, with counties labeled).
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Figure 2.1: Rate of Selected Major Birth Defects by ADD, per 10,000 Live Births,
Kentucky, 2005 through 2014

This figure was prepared by Emily Ferrell, MPH CPH, from the Division of Maternal and
Child Health at the Kentucky Department for Public Health, and was originally presented
in the 2005-2014 Kentucky Birth Surveillance Report (KBSR), which was released
August 2016.46 Data used to create this figure was retrieved from the Kentucky Birth
Surveillance Registry, Kentucky Live Birth Certificates, and Kentucky Stillbirth
certificates. Selected major birth defects included critical congenital heart defects,
orofacial clefts, down syndrome, neural tube defects, diaphragmatic hernia, and
gastroschisis. Rates shown are per 10,000 live births.
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